-
1
-
-
0030051777
-
Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus
-
Behrens, S.-E., Tomei, L., and De Francesco, R., Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J., 15, 12-22 (1996).
-
(1996)
EMBO J.
, vol.15
, pp. 12-22
-
-
Behrens, S.-E.1
Tomei, L.2
De Francesco, R.3
-
2
-
-
0032503562
-
A novel class of oligonucleotide analogs containing 2'-O,3'-C-Linked [3.2.0]bicycloarabino-nucleoside monomers: Synthesis, thermal affinity studies, and molecular modeling
-
Christensen, N. K., Petersen, M., Nielsen, P., Jacobsen, J. P., Olsen, C., and Wengel, J., A novel class of oligonucleotide analogs containing 2'-O,3'-C-Linked [3.2.0]bicycloarabino-nucleoside monomers: Synthesis, thermal affinity studies, and molecular modeling. J. Am. Chem. Soc., 120, 5458-5463 (1998).
-
(1998)
J. Am. Chem. Soc.
, vol.120
, pp. 5458-5463
-
-
Christensen, N.K.1
Petersen, M.2
Nielsen, P.3
Jacobsen, J.P.4
Olsen, C.5
Wengel, J.6
-
3
-
-
34848902599
-
Synthesis of 3'-deoxy-3'-C-methyl-β-D-ribonucleoside analogs
-
Couturier, S., Aljarah, M., Gosselin, G., Mathe, C., and Perigaud, C., Synthesis of 3'-deoxy-3'-C-methyl-β-D-ribonucleoside analogs. Tetrahedron, 63, 11260-11266 (2007) and references cited therein.
-
(2007)
Tetrahedron
, vol.63
, pp. 11260-11266
-
-
Couturier, S.1
Aljarah, M.2
Gosselin, G.3
Mathe, C.4
Perigaud, C.5
-
4
-
-
11144355286
-
Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase
-
Eldrup, A. B., Allerson, C. R., Bennett, C. F., Bera, S., Bhat, B., Bhat, N., Bosserman, M. R., Brooks, J., Burlein, C., Carroll, S. S., Cook, P. D., Getty, K. L., MacCoss, M., McMasters, D. R., Olsen, D. B., Prakash, T. P., Prhavc, M., Song, Q., Tomassini, J. E., and Xia, J., Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase. J. Med. Chem., 47, 2283-2295 (2004).
-
(2004)
J. Med. Chem.
, vol.47
, pp. 2283-2295
-
-
Eldrup, A.B.1
Allerson, C.R.2
Bennett, C.F.3
Bera, S.4
Bhat, B.5
Bhat, N.6
Bosserman, M.R.7
Brooks, J.8
Burlein, C.9
Carroll, S.S.10
Cook, P.D.11
Getty, K.L.12
MacCoss, M.13
McMasters, D.R.14
Olsen, D.B.15
Prakash, T.P.16
Prhavc, M.17
Song, Q.18
Tomassini, J.E.19
Xia, J.20
more..
-
5
-
-
12144260229
-
Control of hepatitis C: A medicinal chemistry perspective
-
Gordon, C. P. and Keller, P. A., Control of hepatitis C: A medicinal chemistry perspective, J. Med. Chem., 48, 1-20 (2005).
-
(2005)
J. Med. Chem.
, vol.48
, pp. 1-20
-
-
Gordon, C.P.1
Keller, P.A.2
-
6
-
-
15644379995
-
Nucleosides and nucleotides. 175. structural requirements of the sugar moiety for the antitumor activities of new nucleoside antimetabolites, 1-(3-C-Ethynyl-β-D-ribo-pentofuranosyl)cytosine and-uracil
-
Hattori, H., Nozawa, E., Iino, T., Yoshimura, Y., Shuto, S., Shimamoto, Y., Nomura, M., Fukushima, M., Tanaka, M., Sasaki, T., and Matsuda, A., Nucleosides and nucleotides. 175. structural requirements of the sugar moiety for the antitumor activities of new nucleoside antimetabolites, 1-(3-C-Ethynyl-β-D-ribo-pentofuranosyl)cytosine and-uracil. J. Med. Chem., 41, 2892-2902 (1998).
-
(1998)
J. Med. Chem.
, vol.41
, pp. 2892-2902
-
-
Hattori, H.1
Nozawa, E.2
Iino, T.3
Yoshimura, Y.4
Shuto, S.5
Shimamoto, Y.6
Nomura, M.7
Fukushima, M.8
Tanaka, M.9
Sasaki, T.10
Matsuda, A.11
-
7
-
-
0030928695
-
Hepatitis C: The clinical spectrum of disease
-
Hoofnagle, J. H., Hepatitis C: the clinical spectrum of disease. Hepatology, 26, 15S-20S (1997).
-
(1997)
Hepatology
, vol.26
-
-
Hoofnagle, J.H.1
-
8
-
-
0141426802
-
Current and future therapy for chronic hepatitis C virus liver disease
-
Lake-Bakaar, G., Current and future therapy for chronic hepatitis C virus liver disease. Curr. Drug Targets Infect. Disord., 3, 247-253 (2003).
-
(2003)
Curr. Drug Targets Infect. Disord.
, vol.3
, pp. 247-253
-
-
Lake-Bakaar, G.1
-
9
-
-
1542677267
-
Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro
-
Migliaccio, G., Tomassini, J. E., Carroll, S. S., Tomei, L., Altamura, S., Bhat, B., Bartholomew, L., Bosserman, M. R., Ceccacci, A., Colwell, L. F., Cortese, R., De Francesco, R., Eldrup, A. B., Getty, K. L., Hou, X. S., LaFemina, R. L., Ludmerer, S. W., MacCoss, M., McMasters, D. R., Stahlhut, M. W., Olsen, D. B., hazuda, D. J., and Flores, O. A., Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro. J. Biol. Chem., 278, 49164-49170 (2003).
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 49164-49170
-
-
Migliaccio, G.1
Tomassini, J.E.2
Carroll, S.S.3
Tomei, L.4
Altamura, S.5
Bhat, B.6
Bartholomew, L.7
Bosserman, M.R.8
Ceccacci, A.9
Colwell, L.F.10
Cortese, R.11
De Francesco, R.12
Eldrup, A.B.13
Getty, K.L.14
Hou, X.S.15
Lafemina, R.L.16
Ludmerer, S.W.17
MacCoss, M.18
McMasters, D.R.19
Stahlhut, M.W.20
Olsen, D.B.21
Hazuda, D.J.22
Flores, O.A.23
more..
-
11
-
-
1342301749
-
Viral hepatitis: New data on hepatitis C infection
-
Szabo, E., Lotz, G., Paska, C., Kiss, A., and Schaff, Z., Viral hepatitis: new data on hepatitis C infection. Pathol. Oncol. Res., 9, 215 (2003).
-
(2003)
Pathol. Oncol. Res.
, vol.9
, pp. 215
-
-
Szabo, E.1
Lotz, G.2
Paska, C.3
Kiss, A.4
Schaff, Z.5
-
12
-
-
33745727138
-
Synthesis of 2-C-hydroxymethylribofuranosylpurines as potent anti-hepatitis C virus (HCV) agent
-
Yoo, B. N., Kim, H. O., Moon, H. R., Seol, S. K., Jang, S. K., Lee, K. M., and Jeong, L. S., Synthesis of 2-C-hydroxymethylribofuranosylpurines as potent anti-hepatitis C virus (HCV) agent. Bioorg. Med. Chem. Lett., 16, 4190-4194 (2006).
-
(2006)
Bioorg. Med. Chem. Lett.
, vol.16
, pp. 4190-4194
-
-
Yoo, B.N.1
Kim, H.O.2
Moon, H.R.3
Seol, S.K.4
Jang, S.K.5
Lee, K.M.6
Jeong, L.S.7
|